Modified vaccinia virus Ankara as a vector for suicide gene therapy (Q40054213)

16 September 2017

Modified vaccinia virus Ankara as a vector for suicide gene therapy (English)

1 reference

16 September 2017

0 references

0 references

0 references

vaccinia virus

1 reference

Erbs P

1

1 reference

16 September 2017

Findeli A

2

1 reference

16 September 2017

Kintz J

3

1 reference

16 September 2017

Cordier P

4

1 reference

16 September 2017

Hoffmann C

5

1 reference

16 September 2017

Geist M

6

1 reference

16 September 2017

Balloul JM

7

1 reference

16 September 2017

9 November 2007

1 reference

16 September 2017

1 reference

16 September 2017

15

1 reference

16 September 2017

1

1 reference

16 September 2017

18-28

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701098

16 September 2017

0 references

cites work

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Hypoxia-induced cytosine deaminase gene expression for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Characterization of the upp gene encoding uracil phosphoribosyltransferase of Escherichia coli K12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

The FUR1 gene of Saccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Nonreplicating vaccinia vector efficiently expresses recombinant genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

7 January 2021

The metabolism of 5-fluorocytosine-214C and of cytosine-14C in the rat and the disposition of 5-fluorocytosine-214C in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

7 January 2021

MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

7 January 2021

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

7 January 2021

Association of intratumoral pharmacokinetics of fluorouracil with clinical response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

7 January 2021

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701098

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701098

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference